Once-monthly oral ibandronate improves biomechanical determinants of bone strength in women with postmenopausal osteoporosis.
暂无分享，去创建一个
H. Genant | T. Fuerst | T. Keaveny | D. Kopperdahl | K. Engelke | E. Lewiecki | L. Fitzpatrick | A. Kivitz | R. Davies | Usa | Germany | E. M. Lewiecki | O. N. Diagnostics | Osteoporosis Director | Eli Lilly | Upsher-Smith